Literature DB >> 1886456

Clinical effects of methamphetamine vapor inhalation.

M Perez-Reyes1, W R White, S A McDonald, J M Hill, A R Jeffcoat, C E Cook.   

Abstract

Despite the increasing popularity of crystalline methamphetamine ("ice") vapor inhalation, no investigations have reported drug plasma concentrations and effects. Under controlled laboratory conditions, six subjects were studied. Plasma concentrations of methamphetamine were determined, and subjective and cardiovascular effects were measured. Methamphetamine appeared in plasma rapidly, increased slowly over the next four hours and then progressively declined. The dose of methamphetamine administered produced modest ratings of subjective drug effects, and moderate changes in cardiovascular parameters. Both subjective and cardiovascular effects rapidly decreased despite the presence of sustained concentrations of methamphetamine in plasma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886456     DOI: 10.1016/0024-3205(91)90078-p

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems.

Authors:  Cristina Miliano; E Reilly Scott; Laura B Murdaugh; Emma R Gnatowski; Christine L Faunce; Megan S Anderson; Malissa M Reyes; Ann M Gregus; Matthew W Buczynski
Journal:  J Neurosci Methods       Date:  2019-10-12       Impact factor: 2.390

2.  Reinforcing effects of smoked methamphetamine in rhesus monkeys.

Authors:  Jennifer L Newman; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

3.  Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers.

Authors:  Christopher D Verrico; James J Mahoney; Daisy G Y Thompson-Lake; Ryan S Bennett; Thomas F Newton; Richard De La Garza
Journal:  Int J Neuropsychopharmacol       Date:  2014-02       Impact factor: 5.176

4.  Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake.

Authors:  S Shabani; C S McKinnon; C Reed; C L Cunningham; T J Phillips
Journal:  Genes Brain Behav       Date:  2011-05-31       Impact factor: 3.449

Review 5.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

6.  Acute effects of MDMA on autonomic cardiac activity and their relation to subjective prosocial and stimulant effects.

Authors:  Christine M Clark; Charles G Frye; Margaret C Wardle; Greg J Norman; Harriet de Wit
Journal:  Psychophysiology       Date:  2014-09-11       Impact factor: 4.016

Review 7.  Pharmacologic mechanisms of crystal meth.

Authors:  Stephen J Kish
Journal:  CMAJ       Date:  2008-06-17       Impact factor: 8.262

8.  Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae.

Authors:  Minseon Park; Bernhard Hennig; Michal Toborek
Journal:  J Cell Mol Med       Date:  2012-02       Impact factor: 5.310

9.  Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates.

Authors:  Ziva D Cooper; Suzette M Evans; Richard W Foltin
Journal:  Exp Clin Psychopharmacol       Date:  2021-04       Impact factor: 3.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.